Fulgent Genetics, Inc.
(NASDAQ: FLGT)

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

28.135

-0.165 (-0.58%)
Range 28.045 - 28.570   (1.87%)
Open 28.420
Previous Close 28.300
Bid Price 38.860
Bid Volume 8
Ask Price 41.750
Ask Volume 11
Volume 11,049
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis